These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3926510)

  • 21. Increased excretion of kallikrein during dexamethasone administration in normal man on low and normal salt intake.
    López JM; Arteaga E; Rodriguez JA; Croxatto H
    Clin Sci (Lond); 1983 Nov; 65(5):487-90. PubMed ID: 6555065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
    Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
    Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced ratio of active-to-total urinary kallikrein in essential hypertension.
    Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG
    Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Krück F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():263s-265s. PubMed ID: 261517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
    Kamata Y; Fujita T; Kato T; Hayashi I; Kurosaka M; Katori M; Fujita Y; Majima M
    Hypertens Res; 2009 Mar; 32(3):220-6. PubMed ID: 19262486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A; Stumpe KO; Müller HM; Kolloch R; Higuchi M
    Klin Wochenschr; 1982 Oct; 60(19):1223-8. PubMed ID: 6183482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium sensitivity in essential hypertension: role of the renin-angiotensin-aldosterone system and predictive value of an intravenous frusemide test.
    Koolen MI; van Brummelen P
    J Hypertens; 1984 Feb; 2(1):55-9. PubMed ID: 6530538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes.
    Zinner SH; Margolius HS; Rosner B; Keiser HR; Kass EH
    Am J Epidemiol; 1976 Aug; 104(2):124-32. PubMed ID: 952282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between blood pressure and sodium and potassium excretion during the day and at night.
    Staessen JA; Birkenhäger W; Bulpitt CJ; Fagard R; Fletcher AE; Lijnen P; Thijs L; Amery A
    J Hypertens; 1993 Apr; 11(4):443-7. PubMed ID: 8390513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive glandular kallikrein in plasma during alterations of urinary kallikrein excretion.
    Rabito SF; Scicli AG; Carretero OA
    Hypertension; 1983; 5(6 Pt 3):V153-7. PubMed ID: 6558003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control.
    Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA
    J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of urinary kallikrein activity to renal salt and water excretion.
    Levy SB; Frigon RP; Stone RA
    Clin Sci Mol Med; 1978 Jan; 54(1):39-45. PubMed ID: 620492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
    J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences of human tissue kallikrein and an erythrocyte kallikrein-like enzyme in essential hypertension.
    Hughes GS; Margolius HS; Peters R; Oexmann MJ; Chao J; Lindenmayer G
    J Lab Clin Med; 1988 Nov; 112(5):612-8. PubMed ID: 3183493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.